149 related articles for article (PubMed ID: 38342870)
1. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract][Full Text] [Related]
2. Relation of Neutrophil-Lymphocyte Ratio with Clinical Severity in Patients with Guillain-Barre Syndrome.
Banerjee S; Bhattacharjee M; Hossain MI; Hossain MS; Roy S; Shahiduzzaman M; Dey S; Losy SA
Mymensingh Med J; 2023 Jul; 32(3):599-605. PubMed ID: 37391946
[TBL] [Abstract][Full Text] [Related]
3. Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barré syndrome.
Xu L; Gao TX; Chang SH; Jiang SM; Zhang LJ; Yang L
J Clin Neurosci; 2022 Nov; 105():31-36. PubMed ID: 36063751
[TBL] [Abstract][Full Text] [Related]
4. Early predictors of functional disability in Guillain-Barré Syndrome.
Tunç A
Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
[TBL] [Abstract][Full Text] [Related]
5. Sensory symptoms on admission as a predictor of respiratory insufficiency in patients of Guillain-Barre Syndrome (GBS).
Aslam A; Anwar I; Tariq A
J Pak Med Assoc; 2021 Feb; 71(2(A)):446-448. PubMed ID: 33819225
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of systemic immune-inflammation index and platelet/neutrophil to lymphocyte ratio in Guillain-Barré syndrome.
Liu T; Gao J; Liu M
Clin Neurol Neurosurg; 2023 Dec; 235():108015. PubMed ID: 37898029
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-lymphocyte ratio in Guillain-Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh.
Jahan I; Ahmed R; Ahmed J; Khurshid S; Biswas PP; Upama IJ; Hamid Y; Papri N; Islam Z
J Peripher Nerv Syst; 2023 Mar; 28(1):47-57. PubMed ID: 36700342
[TBL] [Abstract][Full Text] [Related]
8. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.
Gong Q; Liu S; Xiao Z; Fu X; Lu Z
Neurol Res; 2022 Feb; 44(2):121-127. PubMed ID: 34382919
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Protein Level and Mechanical Ventilation in Guillain-Barré Syndrome patients.
Davalos L; Nowacek D; Elsheikh B; Reynolds EL; Maher Stino A
J Neuromuscul Dis; 2021; 8(2):299-303. PubMed ID: 33459659
[TBL] [Abstract][Full Text] [Related]
10. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.
Bourque PR; Brooks J; Warman-Chardon J; Breiner A
J Neurol; 2020 Mar; 267(3):746-751. PubMed ID: 31734909
[TBL] [Abstract][Full Text] [Related]
12. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.
Kong L; Wu X; Cheng Y; Liu S; Liu K; Li C
Neurol Sci; 2022 Aug; 43(8):5017-5028. PubMed ID: 35469074
[TBL] [Abstract][Full Text] [Related]
13. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
[TBL] [Abstract][Full Text] [Related]
14. Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome.
Min YG; Ju W; Seo JW; Ha YE; Ban JJ; Kwon YN; Jeong HY; Shin JY; Kim SM; Hong YH; Kim SJ; Sung JJ
J Neurol Sci; 2023 Jan; 444():120512. PubMed ID: 36462224
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children.
Qinrong H; Yuxia C; Ling L; Huayu L; Lei X; Xiaoli L; Nong X
Dev Med Child Neurol; 2023 Apr; 65(4):563-570. PubMed ID: 36175376
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome.
Ozdemir HH
Arq Neuropsiquiatr; 2016 Sep; 74(9):718-722. PubMed ID: 27706420
[TBL] [Abstract][Full Text] [Related]
17. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
[TBL] [Abstract][Full Text] [Related]
18. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
[TBL] [Abstract][Full Text] [Related]
19. Are Cerebrospinal Fluid Protein Levels and Plasma Neutrophil/Lymphocyte Ratio Associated with Prognosis of Guillain Barré Syndrome?
Sahin S; Cinar N; Karsidag S
Neurol Int; 2017 Jun; 9(2):7032. PubMed ID: 28713530
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome.
Ning P; Yang B; Yang X; Huang H; Shen Q; Zhao Q; Xie D; Lu H; Xu Y
J Neuroimmunol; 2021 Apr; 353():577504. PubMed ID: 33548620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
